Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in Obese Patients with Binge Eating Disorder
NCT00481975Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of rimonabant in obesity, binge eating disorder (BED), sponsored by Sanofi. Started Aug 2004; status: completed.
02
Drugs
rimonabant
03
Conditions
obesitybinge eating disorder (BED)
Beyond the preview
Go deeper on NCT00481975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481975.